
NMRA
USDNeumora Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$2.560
Максимум
$2.920
Минимум
$2.550
Объем
1.60M
Фундаментальные показатели компании
Рыночная капитализация
480.9M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.36M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model
NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading
Связанные акции
VCTR
Victory Capital Holdings Inc.
IMTX
Immatics N.V. Ordinary Shares
TVC
Tennessee Valley Authority
EMCGR
Embrace Change Acquisition Corp Rights
MPLX
MPLX LP Common Units Representing Limited Partner Interests
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.